Recombinant Uncharacterized protein Rv2077c/MT2137, also known as Rv2077c or MT2137, is a protein of Mycobacterium tuberculosis that is not yet fully characterized . Despite the lack of comprehensive understanding of its function, research indicates its involvement in bacterial survival mechanisms and potential interactions with other proteins .
While the precise function of Rv2077c/MT2137 remains uncharacterized, studies suggest its involvement in several pathways and biochemical functions :
Involved Pathways Rv2077c/MT2137 participates in various pathways, suggesting it has multiple roles within the cell .
Biochemical Functions This protein has several biochemical functions that may act alone or in cooperation with other proteins .
Interacting Proteins Rv2077c/MT2137 interacts directly with other proteins and molecules, as detected through methods like yeast two-hybrid assays, co-immunoprecipitation, and pull-down assays .
Rv2077c/MT2137 is significant for the survival and virulence of Mycobacterium tuberculosis . Mutants with disruptions in the Rv2077c/MT2137 gene exhibit attenuation under hypoxic conditions, indicating its role in the bacterium's adaptation to low-oxygen environments .
Tn insertion mutants of Rv2077c/MT2137 showed reduced CFU counts relative to the isogenic wild-type strain by Day 28 after entry into NRP-2 .
| MT# | Rv# | Name | Models Attenuated | Fold Attenuation |
|---|---|---|---|---|
| MT2137 | Rv2077c | - | R, Mo HF, GP Aero | 4.25 |
R = in vitro progressive hypoxia (reference) model; HF = mouse implantable hollow fiber model; Mo Aero = mouse aerosol model; GP Aero = guinea pig aerosol model .
Rv2077c is predicted to be co-regulated in modules bicluster_0322 with residual 0.56 and bicluster_0395 with residual 0.54 . This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.00 and 350.00 for bicluster_0322 and 0.00 and 760.00 for bicluster_0395 respectively .
Rv2077c (MT2137) is an uncharacterized protein in Mycobacterium tuberculosis that has been identified as a possible membrane protein. Research indicates that Rv2077c plays a significant role in bacterial survival under various stress conditions. According to experimental data, Rv2077c-deficient mutant strains show attenuated growth in multiple experimental models, including reference hypoxia models, mouse hollow fiber models, and guinea pig aerosol models .
The protein is encoded by a 972-nucleotide gene located at position 2333323-2334294 on the negative strand of the MTB genome, producing a protein of 323 amino acids . While its exact function remains to be fully characterized, experimental evidence suggests involvement in stress response pathways that contribute to MTB survival in host environments.
Multiple experimental models have confirmed the role of Rv2077c in MTB pathogenesis, with consistent evidence of attenuation when this gene is disrupted. According to published data, the following models have demonstrated the importance of Rv2077c:
| Model Type | Attenuation Observed | Fold Attenuation |
|---|---|---|
| In vitro progressive hypoxia (reference) model | Yes | 4.25 |
| Mouse hollow fiber model | Yes | Significant |
| Guinea pig aerosol model | Yes | Significant |
This pattern of attenuation across different model systems suggests that Rv2077c participates in adaptation mechanisms crucial for MTB survival in diverse host environments . The consistent attenuation in both in vitro and in vivo models indicates that this protein may be important in multiple stages of infection.
When designing expression systems for recombinant Rv2077c, several parameters must be optimized:
Expression System Selection: E. coli has been successfully used for recombinant expression of mycobacterial membrane proteins, including Rv2077c. For more complex studies requiring eukaryotic post-translational modifications, consider insect cell systems like Sf9 .
Critical Parameters for Optimization:
Cell count at infection (CCI): Optimal range is 5-6 × 10^6 cells/ml
Multiplicity of infection (MOI): 1.5-2.0 typically yields good results
Temperature: Lower temperatures (23-25°C) often improve membrane protein folding
Additives: Consider adding membrane stabilizers like pluronic F-68 (0.3-0.4%)
Induction Conditions: For E. coli systems, IPTG concentration and induction temperature significantly impact protein folding. Lower temperatures (16-18°C) with extended expression times often improve membrane protein solubility.
Purification Strategy: Include detergents appropriate for membrane proteins (e.g., n-dodecyl β-D-maltoside) during cell lysis and purification steps. His-tagged constructs of Rv2077c have been successfully purified using immobilized metal affinity chromatography .
Application of experimental design methodology (DOE) with response surface methodology can significantly improve recombinant protein yields, as demonstrated with other complex proteins .
When designing experiments to study Rv2077c function in pathogenesis, a systematic approach is essential:
Study Design Framework:
Recommended Experimental Design Approach:
Model Systems Selection:
Control Considerations:
Data Analysis Plan:
Characterizing protein-protein interactions for membrane proteins like Rv2077c requires specialized approaches:
In Vitro Interaction Assays:
Pull-down assays: Using recombinant His-tagged Rv2077c as bait to identify binding partners from mycobacterial lysates or host cell extracts
Surface Plasmon Resonance (SPR): For quantitative measurement of binding kinetics with purified interaction partners
Isothermal Titration Calorimetry (ITC): To determine thermodynamic parameters of interactions
Cellular Interaction Systems:
Bacterial Two-Hybrid (B2H): Particularly useful for membrane proteins when traditional Y2H may fail
Split-GFP Complementation: Allows visualization of interactions in living cells
Co-immunoprecipitation (Co-IP): Using specific antibodies against Rv2077c to pull down protein complexes from mycobacterial lysates
Advanced Structural Approaches:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): To map interaction interfaces
Crosslinking Mass Spectrometry (XL-MS): For capturing transient interactions
Cryo-Electron Microscopy: For structural characterization of membrane protein complexes
Computational Prediction:
Molecular dynamics simulations to predict protein-protein interfaces
Machine learning approaches for interaction partner prediction based on homology
When designing these experiments, researchers should include appropriate controls, such as known interaction partners or non-interacting proteins, to validate the specificity of observed interactions.
Research indicates that Rv2077c plays a significant role in MTB adaptation to hypoxia, a key stress condition encountered during infection:
Evidence from Hypoxia Models:
Potential Molecular Mechanisms:
As a putative membrane protein, Rv2077c may be involved in:
Maintaining membrane integrity under hypoxic stress
Modulating redox balance across the cell membrane
Facilitating nutrient acquisition under stress conditions
Signal transduction for hypoxia-responsive gene regulation
Relationship to Known Hypoxia Response Pathways:
Experimental Approaches to Elucidate Mechanisms:
Transcriptomic analysis of ΔRv2077c mutants under hypoxia to identify dysregulated pathways
Metabolomic profiling to identify altered metabolic pathways
Membrane potential measurements to assess membrane function
Redox state analysis using fluorescent probes
Understanding the precise molecular mechanisms of Rv2077c function in hypoxia adaptation would provide insights into MTB persistence and potentially identify new drug targets for latent TB infection.
Creating and validating Rv2077c knockout mutants requires careful methodology to ensure specificity and completeness of gene disruption:
Knockout Strategy Options:
Homologous Recombination: Traditional approach using suicide vectors containing antibiotic resistance markers flanked by Rv2077c homologous regions
Specialized Transduction: Phage-based delivery of allelic exchange substrates (more efficient than plasmid-based methods)
CRISPR-Cas9: Emerging technique for mycobacteria allowing precise genomic editing
Detailed Protocol Framework:
Design constructs with at least 500-800 bp homology arms flanking Rv2077c
Include selectable markers (hygromycin or kanamycin resistance)
Consider unmarked deletion strategies using γδ-resolvase or Cre-loxP for multiple genetic manipulations
Perform electroporation into MTB using optimized parameters for highest efficiency
Comprehensive Validation Strategy:
Genomic confirmation:
PCR verification using primers outside the recombination region
Southern blot analysis to confirm single integration at the correct locus
Transcriptional confirmation:
RT-PCR to verify absence of Rv2077c transcript
RNA-Seq to assess potential polar effects on adjacent genes
Protein confirmation:
Western blot using anti-Rv2077c antibodies
Proteomics approaches to confirm absence of protein
Complementation Controls:
Create complementation constructs using integrative vectors (e.g., pMV306)
Use the native promoter region (approximately 500 bp upstream) for physiological expression levels
Include epitope tags for detection if antibodies aren't available
Verify complementation by restoration of wild-type phenotypes in key assays
This comprehensive knockout and validation strategy ensures that observed phenotypes can be confidently attributed to the absence of Rv2077c rather than polar effects or secondary mutations .
To comprehensively assess the impact of Rv2077c on MTB survival, researchers should employ multiple complementary assays:
In Vitro Survival Assays:
Hypoxia Adaptation: Wayne model or microfluidic devices with oxygen sensors
Nutrient Starvation: PBS starvation model with CFU enumeration at defined timepoints
Acid Stress Survival: Exposure to acidified media (pH 4.5-5.5) mimicking phagosomal conditions
Oxidative/Nitrosative Stress: H₂O₂ or NO donor exposure with survival quantification
Cellular Infection Models:
Macrophage Survival Assay: Infection of primary macrophages or cell lines with CFU enumeration
Intracellular Trafficking Analysis: Fluorescence microscopy to track phagosomal maturation
Cell Death Modulation: Measure apoptosis vs. necrosis in infected macrophages using flow cytometry
Cytokine Response: Quantify pro/anti-inflammatory cytokine production using ELISA or multiplex assays
Animal Model Approaches:
High-Throughput Screening Approaches:
Key Metrics for Quantification:
Colony-forming units (CFU): For bacterial survival measurement
Relative competitive index (RCI): For mixed-infection competition assays
Bacterial burden in tissues: By CFU or quantitative PCR
Histopathological scoring of lesions: For in vivo virulence assessment
When implementing these assays, rigorous controls and sufficient biological replicates are essential. For in vivo studies, power analysis should be conducted to determine appropriate sample sizes, and experiments should be designed to minimize animal usage while maintaining statistical validity .
Response Surface Methodology (RSM) provides a powerful approach for optimizing recombinant protein expression by efficiently exploring multiple variables simultaneously:
Initial Parameter Screening:
RSM Implementation Strategy:
Apply Box-Behnken design for the 3-4 most influential parameters identified in screening
Design experiments with three levels (low, medium, high) for each parameter
Include center points for estimating experimental error
For Rv2077c as a membrane protein, focus on:
Detailed Experimental Design Framework:
| Parameter | Low Level | Middle Level | High Level |
|---|---|---|---|
| Temperature | 18°C | 23°C | 28°C |
| IPTG concentration | 0.1 mM | 0.5 mM | 1.0 mM |
| Cell density (OD₆₀₀) | 0.6 | 1.0 | 1.4 |
| Membrane stabilizer | 0% | 0.2% | 0.4% |
Analysis and Model Development:
Scale-up Considerations:
Verify optimized conditions in larger culture volumes
Monitor key parameters during scale-up (oxygen transfer, mixing, etc.)
Adjust parameters if necessary based on scale-dependent effects
This systematic approach has shown success with complex proteins, improving expression by 3-4 fold compared to standard conditions . For membrane proteins like Rv2077c, RSM is particularly valuable as they often require specific conditions for proper folding and membrane insertion.
Rv2077c research can significantly impact TB drug discovery through multiple approaches:
Target Validation Considerations:
Drug Discovery Approaches:
Target-based screening: Using purified recombinant Rv2077c to screen for direct inhibitors
Phenotypic screening: Testing compounds against wildtype vs. Rv2077c-overexpressing strains
Fragment-based drug discovery: Identifying small molecule binders that can be developed into leads
Structure-based design: Once structural data is available, rational design of inhibitors
Assay Development Strategies:
Develop functional assays reflecting the protein's role in stress response
Create reporter systems linking Rv2077c function to measurable outputs
Design cell-based assays measuring Rv2077c-dependent phenotypes
Translational Research Applications:
Combination therapy assessment: Test Rv2077c inhibitors with existing TB drugs
Resistance studies: Characterize potential resistance mechanisms
Animal model validation: Test candidates in hollow fiber and aerosol infection models
Special Considerations for Membrane Protein Targets:
Focus on inhibiting external domains more accessible to drugs
Consider lipophilicity requirements for compounds targeting transmembrane regions
Develop assays compatible with membrane protein biochemistry
By targeting Rv2077c, researchers may discover compounds effective against both active and latent TB infections due to its role in hypoxia adaptation, potentially addressing a major challenge in TB treatment .
Despite progress in identifying Rv2077c as important for MTB survival, several critical knowledge gaps and contradictions remain:
Functional Characterization Contradictions:
While classified as a "possible membrane protein," definitive evidence for membrane localization and topology is lacking
The protein's biochemical function remains unknown—whether it acts as a transporter, signaling protein, or structural component
The discrepancy between its importance in various models and lack of functional characterization represents a major gap
Regulatory Network Uncertainties:
It remains unclear whether Rv2077c is regulated by known stress-response systems like DosR/DevR
Transcriptomic studies show variable results regarding its induction under stress conditions
The regulatory elements controlling Rv2077c expression are not well characterized
Interaction Partner Contradictions:
Preliminary studies suggest potential protein-protein interactions, but these have not been independently validated
The relationship between Rv2077c and other membrane proteins involved in stress response remains poorly understood
Host-Pathogen Interface Questions:
Whether Rv2077c directly interacts with host factors or simply supports bacterial survival is unknown
If it does interact with host components, the nature and consequences of these interactions are uncharacterized
Methodology Challenges Contributing to Knowledge Gaps:
Technical difficulties in working with membrane proteins have limited structural and biochemical studies
Variability in experimental models makes cross-study comparisons challenging
Limited antibody availability restricts detection approaches
Addressing these knowledge gaps requires integrated approaches combining genetic, biochemical, and structural studies. Particular emphasis should be placed on defining the protein's membrane topology, identifying interaction partners, and establishing its role in regulatory networks controlling stress responses .
Distinguishing direct from indirect effects of Rv2077c on pathogenesis requires sophisticated experimental designs:
Temporal Analysis Approaches:
Implement time-course experiments using inducible expression systems
Analyze immediate vs. delayed responses after Rv2077c expression/repression
Early response genes/processes (0-6 hours) are more likely to represent direct effects
Molecular Interaction Studies:
Use techniques like ChIP-seq (for DNA interactions) or CLIP-seq (for RNA interactions) to identify direct binding targets
Implement proximity labeling approaches (BioID, APEX) to identify proteins in close physical association with Rv2077c
Validate interactions using in vitro binding assays with purified components
Genetic Approach Framework:
Create point mutations in functional domains to disrupt specific activities while maintaining protein expression
Implement synthetic genetic array analysis to identify genetic interactions
Use epistasis analysis with double mutants to establish pathway relationships
Biochemical Function Determination:
Purify recombinant protein for in vitro activity assays
Test enzymatic functions based on bioinformatic predictions
Analyze post-translational modifications that may regulate activity
Systems Biology Integration:
Combine transcriptomics, proteomics, and metabolomics to build causal networks
Apply mathematical modeling to distinguish direct effects from downstream consequences
Implement Bayesian network analysis to infer causal relationships
Experimental Controls and Validation:
Include appropriate time-matched controls for all experiments
Use complementary approaches to validate findings
Implement dose-response studies to establish causality
By systematically applying these approaches, researchers can build a comprehensive model distinguishing primary functions of Rv2077c from secondary effects, enabling more accurate understanding of its role in pathogenesis and potentially revealing new intervention strategies .